"Siemens" fructosamine reagent group
Taiwan·Risk Class 2·RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.·Registered Jan 07, 2019 – Jan 07, 2029Active- Analysis ID
- b140c90bec8265c7fda03a13561fe2c3
- Customs Code
- DHA05603200504
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
- Intended Use
- This product is used for in vitro diagnostics, and needs to be used with Atellica CH Analyzer to quantitatively detect glycated proteins (fructosamine) in human serum and plasma (heparin lithium, EDTA potassium salt).
- Product Type (Level 1)
- B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 calibration;; B.7470 Analysis of glycosylated hemoglobin
- Import Information
- Input;; Contract manufacturing
- Registration Date
- Jan 07, 2019
- Expiry Date
- Jan 07, 2029
Top companies providing products similar to ""Siemens" fructosamine reagent group"
Recently registered similar products
Access comprehensive regulatory information for "Siemens" fructosamine reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b140c90bec8265c7fda03a13561fe2c3 and manufactured by RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.